Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification And Intensification Clinical Trial Evaluation (GUIDANCE)
Eligible for screening study DCP 001
GU010 will close to accrual effective February 25, 2026, at 5:00pm ET.
GU010 intensification cohort (Groups 3 and 4) are closed to accrual at 5 PM ET November 22, 2024
